Browse > Article
http://dx.doi.org/10.3340/jkns.2015.58.4.368

Chronological Changes of C-Reactive Protein Levels Following Uncomplicated, Two-Staged, Bilateral Deep Brain Stimulation  

Kim, Jae-hun (Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea)
Ha, Sang-woo (Department of Neurosurgery, Chosun University Hospital, Chosum University College of Medicine)
Choi, Jin-gyu (Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea)
Son, Byung-chul (Department of Neurosurgery, St. Mary's Hospital, The Catholic University of Korea)
Publication Information
Journal of Korean Neurosurgical Society / v.58, no.4, 2015 , pp. 368-372 More about this Journal
Abstract
Objective : The occurrence of acute cerebral infection following deep brain stimulation (DBS) is currently being reported with elevation of C-reactive protein (CRP) level. The aim of the present study was to establish normal range of the magnitude and time-course of CRP increases following routine DBS procedures in the absence of clinical and laboratory signs of infection. Methods : A retrospective evaluation of serial changes of plasma CRP levels in 46 patients undergoing bilateral, two-staged DBS was performed. Because DBS was performed as a two-staged procedure involving; implantation of lead and internal pulse generator (IPG), CRP was measured preoperatively and postoperatively every 2 days until normalization of CRP (post-lead implantation day 2 and 4, post-IPG implantation day 2, 4, and 6). Results : Compared with preoperative CRP levels ($0.12{\pm}0.17mg/dL$, n=46), mean CRP levels were significantly elevated after lead insertion day 2 and 4 ($1.68{\pm}1.83mg/dL$, n=46 and $0.76{\pm}0.38mg/dL$, n=16, respectively, p<0.001). The mean CRP levels at post-lead implantation day 2 were further elevated at post-IPG implantation day 2 ($3.41{\pm}2.56mg/dL$, n=46, respectively, p<0.01). This elevation in post-IPG day 2 rapidly declined in day 4 ($1.24{\pm}1.29mg/dL$, n=46, p<0.05) and normalized to preoperative value at day 6 ($0.42{\pm}0.33mg/dL$, n=46, p>0.05). Mean CRP levels after IPG implantation were significantly higher in patients whose IPGs were implanted at post-lead day 3 than those at post-lead day 5-6 ($3.99{\pm}2.80mg/dL$, n=30, and $2.31{\pm}1.56mg/dL$, n=16, respectively, p<0.05). However, there was no difference in post-IPG day 2 and 4 between them (p>0.05). Conclusion : The mean postoperative CRP levels were highest on post-IPG insertion day 2 and decreased rapidly, returning to the normal range on post-IPG implantation day 6. The duration of post-lead implantation period influenced the magnitude of CRP elevation at post-IPG insertion day 2. Information about the normal response of CRP following DBS could help to avoid unnecessary diagnostic and therapeutic efforts.
Keywords
C-reactive protein; Deep brain stimulation; Inflammation; Intracerebral infection;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Al-Jabi Y, El-Shawarby A : Value of C-reactive protein after neurosurgery : a prospective study. Br J Neurosurg 24 : 653-659, 2010   DOI
2 Bengzon J, Grubb A, Bune A, Hellstrom K, Lindstrom V, Brandt L : Creactive protein levels following standard neurosurgical procedures. Acta Neurochir (Wien) 145 : 667-670; discussion 670-671, 2003   DOI
3 Bhatia S, Oh M, Whiting T, Quigley M, Whiting D : Surgical complications of deep brain stimulation. A longitudinal single surgeon, single institution study. Stereotact Funct Neurosurg 86 : 367-372, 2008   DOI
4 Bjerknes S, Skogseid IM, Sæhle T, Dietrichs E, Toft M : Surgical site infections after deep brain stimulation surgery : frequency, characteristics and management in a 10-year period. PLoS One 9 : e105288, 2014   DOI
5 Blomstedt P, Bjartmarz H : Intracerebral infections as a complication of deep brain stimulation. Stereotact Funct Neurosurg 90 : 92-96, 2012   DOI
6 Carr WP : The role of the laboratory in rheumatology. Acute-phase proteins. Clin Rheum Dis 9 : 227-239, 1983
7 Chou YC, Lin SZ, Hsieh WA, Lin SH, Lee CC, Hsin YL, et al. : Surgical and hardware complications in subthalamic nucleus deep brain stimulation. J Clin Neurosci 14 : 643-649, 2007   DOI
8 Constantoyannis C, Berk C, Honey CR, Mendez I, Brownstone RM : Reducing hardware-related complications of deep brain stimulation. Can J Neurol Sci 32 : 194-200, 2005   DOI
9 Deligny C, Drapier S, Verin M, Lajat Y, Raoul S, Damier P : Bilateral subthalamotomy through dbs electrodes : a rescue option for device-related infection. Neurology 73 : 1243-1244, 2009   DOI
10 Du Clos TW, Mold C : The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 14 : 289-293, 2001   DOI
11 Falowski S, Ooi YC, Smith A, Verhargen Metman L, Bakay RA : An evaluation of hardware and surgical complications with deep brain stimulation based on diagnosis and lead location. Stereotact Funct Neurosurg 90 : 173-180, 2012   DOI
12 Kindmark CO : Quantitative measurement of C-reactive protein in serum. Clin Chim Acta 26 : 95-98, 1969   DOI
13 Kratz A, Lee-Lewandrowski E, Lewandowski K : The plasma proteins in Lewandrowski K (ed) : Clinical Chemistry : Laboratory Management and Clinical Correlations. Philadelphia : Lippincott, Williams and Wilkins, 2002, pp531-560
14 Merello M, Cammarota A, Leiguarda R, Pikielny R : Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease. Case report. Mov Disord 16 : 168-170, 2001   DOI
15 Mirzayan MJ, Gharabaghi A, Samii M, Tatagiba M, Krauss JK, Rosahl SK : Response of C-reactive protein after craniotomy for microsurgery of intracranial tumors. Neurosurgery 60 : 621-625; discussion 625, 2007   DOI
16 Mustard RA Jr, Bohnen JM, Haseeb S, Kasina R : C-reactive protein levels predict postoperative septic complications. Arch Surg 122 : 69-73, 1987   DOI
17 Nathan BR, Scheld WM : The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 22 : 155-165, 2002
18 Orriss DE : Serial serum C-reactive protein levels as an indicator of infection in cardiac transplant patients. Med Lab Sci 45 : 116-120, 1988
19 Pepper J, Zrinzo L, Mirza B, Foltynie T, Limousin P, Hariz M : The risk of hardware infection in deep brain stimulation surgery is greater at impulse generator replacement than at the primary procedure. Stereotact Funct Neurosurg 91 : 56-65, 2013   DOI
20 Rosahl SK, Gharabaghi A, Zink PM, Samii M : Monitoring of blood parameters following anterior cervical fusion. J Neurosurg 92 (2 Suppl) : 169-174, 2000
21 Schuhmann MU, Ostrowski KR, Draper EJ, Chu JW, Ham SD, Sood S, et al. : The value of C-reactive protein in the management of shunt infections. J Neurosurg 103 (3 Suppl) : 223-230, 2005
22 Sillay KA, Larson PS, Starr PA : Deep brain stimulator hardware-related infections : incidence and management in a large series. Neurosurgery 62 : 360-366; discussion 366-367, 2008   DOI
23 Son BC, Han SH, Choi YS, Kim HS, Kim MC, Yang SH, et al. : Transaxillary subpectoral implantation of implantable pulse generator for deep brain stimulation. Neuromodulation 15 : 260-266; discussion 266, 2012   DOI
24 Tillett WS, Francis T Jr : Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 52 : 561-571, 1930   DOI
25 Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V : Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56 : 548-551, 2001   DOI